How Creatinine Clearance Is Calculated (Cockcroft-Gault)
Creatinine clearance (CrCl) is calculated with the Cockcroft-Gault formula: CrCl (mL/min) = ((140 minus age in years) times weight in kg) divided by (72 times serum creatinine in mg/dL), multiplied by 0.85 if the patient is female. It converts a single serum creatinine reading into an estimate of kidney function, and it is still the reference formula most drug package inserts use for renal dose adjustment.
This guide breaks the formula down, walks through two worked examples (one male, one female, so you can see the 0.85 factor in action), covers the mg/dL to µmol/L conversion, and lists the mistakes that throw the result off.
The formula and why the female multiplier exists
Cockcroft-Gault was published in 1976 and estimates creatinine clearance from four inputs: age, weight, sex, and serum creatinine. Creatinine is a muscle-breakdown byproduct, so the amount a person produces per day depends heavily on muscle mass, not just kidney function. Two patients with identical kidneys but different muscle mass will show different serum creatinine at steady state.
Women have, on average, less muscle mass than men at the same body weight, so they produce less creatinine at any given level of true renal function. Left uncorrected, the raw formula would overestimate a woman’s clearance. The 0.85 multiplier compensates for that, not for a difference in kidney performance itself.
The formula is deliberately simple: no lab-specific calibration, no BSA normalization, just age, weight, sex, and one blood value. That simplicity is exactly why it’s still embedded in so many dosing tables decades after more accurate estimating equations arrived.
Worked example 1: a 60-year-old man
| Factor | Value |
|---|---|
| Age | 60 years |
| Weight | 80 kg |
| Serum creatinine | 1.0 mg/dL |
| Sex | Male (no adjustment) |
CrCl = ((140 − 60) × 80) ÷ (72 × 1.0) = (80 × 80) ÷ 72 = 6400 ÷ 72 ≈ 89 mL/min
That result sits at the top of the “mild reduction” band, just under the normal cutoff of 90 mL/min, which is a common finding in an otherwise healthy 60-year-old and usually doesn’t require any dose adjustment on its own.
Worked example 2: a 55-year-old woman
This one shows the sex adjustment explicitly.
| Factor | Value |
|---|---|
| Age | 55 years |
| Weight | 65 kg |
| Serum creatinine | 0.9 mg/dL |
| Sex | Female (× 0.85) |
Before the sex adjustment: ((140 − 55) × 65) ÷ (72 × 0.9) = (85 × 65) ÷ 64.8 = 5525 ÷ 64.8 ≈ 85.3 mL/min.
Apply the 0.85 multiplier: 85.3 × 0.85 ≈ 72.5 mL/min.
Without the correction the formula would have reported roughly 85 mL/min, which is a full band higher on the reference scale. That 13-point gap is the entire reason the multiplier exists: it’s not a rounding nicety, it changes which kidney-function category the patient lands in.
Calculate it with your own values
Reading the result: CrCl bands
| CrCl (mL/min) | Stage |
|---|---|
| ≥ 90 | Normal |
| 60–89 | Mild reduction |
| 30–59 | Moderate reduction |
| 15–29 | Severe reduction |
| < 15 | Kidney failure |
Both worked examples above land in different bands: the man at ≈89 mL/min is borderline normal/mild, the woman at ≈72.5 mL/min is squarely in the mild-reduction range, which is exactly the kind of distinction that matters when a drug label specifies a renal dose cutoff at, say, 60 or 30 mL/min.
mg/dL vs µmol/L
Serum creatinine is reported in mg/dL in the US and in µmol/L almost everywhere else. The formula needs mg/dL, so a lab result in µmol/L has to be divided by 88.4 first: 1 mg/dL = 88.4 µmol/L.
| µmol/L | mg/dL |
|---|---|
| 88.4 | 1.0 |
| 70.7 | 0.8 |
| 106.1 | 1.2 |
Take a creatinine of 88.4 µmol/L: divide by 88.4 to get 1.0 mg/dL, and that plugs directly into worked example 1 above, giving the same ≈89 mL/min. Skip the conversion and run 88.4 straight through the formula and you get a number 88 times too small, since the denominator (72 × creatinine) balloons out of proportion.
Common mistakes
Using actual body weight in an obese patient. Classic Cockcroft-Gault uses actual body weight, but fat mass doesn’t produce creatinine the way muscle does, so plugging in a high actual weight overestimates clearance. Many hospital protocols substitute an adjusted or ideal body weight once a patient is significantly over their ideal weight, and dosing pharmacists will often flag this before trusting a raw Cockcroft-Gault result.
Trusting it during acute kidney injury. The formula assumes creatinine has reached steady state, meaning production and clearance are in balance. In AKI, creatinine is actively rising or falling, and the formula’s output during that window doesn’t reflect current kidney function, it lags behind it. A rising creatinine will make the formula look better than reality; a falling one will make it look worse.
Overestimating function in low-muscle-mass patients. Elderly patients, amputees, and malnourished patients produce less creatinine to begin with, independent of how well their kidneys filter. Since the formula infers kidney function from creatinine output, low production can mask a real decline in renal function and hand back a falsely reassuring number.
Forgetting the unit conversion. Mixing mg/dL and µmol/L without converting is the single most common arithmetic error with this formula, and it throws the result off by a factor of roughly 88, not a small rounding difference but a result that’s off by nearly two orders of magnitude.
Frequently asked questions
What counts as a normal creatinine clearance?
90 mL/min or higher is considered normal. Values from 60 to 89 mL/min are labeled mild reduction, which is common in older adults and doesn’t always indicate disease on its own, but the trend over time and the clinical context both matter more than a single reading.
How is Cockcroft-Gault different from eGFR (CKD-EPI)?
Cockcroft-Gault reports CrCl in plain mL/min, unadjusted for body size. eGFR formulas like CKD-EPI report glomerular filtration rate normalized per 1.73 m² of body surface area, which makes them better for comparing kidney function across patients of different sizes. The two numbers are not interchangeable, and most drug package inserts specify which one their renal dosing table was built on, historically Cockcroft-Gault, since that’s what the original pharmacokinetic trials used to set dosing thresholds.
Which weight should I use for an obese or underweight patient?
Actual body weight works reasonably well for patients near their ideal weight. For obese patients, many protocols switch to an adjusted body weight (a formula that partially accounts for excess fat mass) or ideal body weight, since actual weight alone overstates clearance. For underweight or low-muscle-mass patients, actual weight is generally used, but the result should be interpreted cautiously since low creatinine production can mask reduced renal function either way.
Is Cockcroft-Gault reliable in acute kidney injury?
No. The formula assumes a stable, steady-state creatinine, and in AKI the creatinine value is actively changing day to day. During that window Cockcroft-Gault (and any other creatinine-based estimate) lags behind the patient’s real-time kidney function and shouldn’t be used alone to guide dosing decisions; clinical judgment and more frequent creatinine trending take priority.
Does the 0.85 female multiplier mean women’s kidneys work worse?
No. It corrects for the fact that women, on average, have less muscle mass and therefore produce less creatinine at any given level of true kidney function. Without the adjustment, the raw formula would systematically overestimate clearance in women, not because their kidneys perform differently, but because the formula’s only proxy for muscle mass is sex.